Inventor · disambiguated record
Weng Tao
Also filed as: TAO WENG
17 granted patents·8 pending applications·262 citations·filing 1994–2024
94Inventor score
Top patents by PatentIndex Score
25 records- 0194US6361771B1ARPE-19 as a platform cell line for encapsulated cell-based deliveryNEUROTECH SA·Filed 2000·Granted Mar 26, 2002·102 cites·14 claims
- 0292US7820195B2Micronized device for the delivery of biologically active molecules and methods of use thereofNEUROTECH USA INC·Filed 2006·Granted Oct 26, 2010·16 cites·25 claims
- 0391US7115257B1ARPE-19 as a platform cell line for encapsulated cell-based deliveryNEUROTECH SA·Filed 2000·Granted Oct 3, 2006·50 cites·3 claims
- 0489US12485087B2Use of encapsulated cell therapy for treatment of ophthalmic disordersNEUROTECH USA INC·Filed 2024·Granted Dec 2, 2025·0 cites·15 claims
- 0589US6225448B11gG /transferrin receptor fusion proteinNEUROTECH SA·Filed 2000·Granted May 1, 2001·29 cites·1 claims
- 0688US11207266B2Use of encapsulated cell therapy for treatment of ophthalmic disordersNEUROTECH USA INC·Filed 2019·Granted Dec 28, 2021·2 cites·16 claims
- 0788US10456356B2Use of encapsulated cell therapy for treatment of ophthalmic disordersNEUROTECH USA INC·Filed 2016·Granted Oct 29, 2019·6 cites·9 claims
- 0887US10195140B2Use of encapsulated cell therapy for treatment of ophthalmic disordersNEUROTECH USA INC·Filed 2017·Granted Feb 5, 2019·5 cites·15 claims
- 0986US12357566B2Use of encapsulated cell therapy for treatment of ophthalmic disordersNEUROTECH USA INC·Filed 2023·Granted Jul 15, 2025·0 cites·15 claims
- 1081US9265814B2Micronized device for the delivery of biologically active molecules and methods of use thereofKAUPER KONRAD·Filed 2006·Granted Feb 23, 2016·9 cites·4 claims
- 1177US2022071897A1Use of encapsulated cell therapy for treatment of ophthalmic disordersNEUROTECH USA INC·Filed 2021·Application pending·0 cites
- 1276US9149427B2Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereofLING VINCENT·Filed 2011·Granted Oct 6, 2015·5 cites·39 claims
- 1371US6197294B1Cell surface molecule-induced macrophage activationNEUROTECH SA·Filed 1998·Granted Mar 6, 2001·21 cites·6 claims
- 1469US6878544B2Retinal cell lines with extended life-span and their applicationsNEUROTECH SA·Filed 2000·Granted Apr 12, 2005·4 cites·1 claims
- 1567US6506891B2Cell surface molecule-induced macrophage activationNEUROTECH SA·Filed 2001·Granted Jan 14, 2003·2 cites·1 claims
- 1662US2009269389A1ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based DeliveryNEUROTECH USA INC·Filed 2009·Application pending·0 cites
- 1762US2009269319A1ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based DeliveryNEUROTECH USA INC·Filed 2009·Application pending·0 cites
- 1854US7189837B2Cell surface molecule-induced macrophage activationNEUROTECH SA·Filed 2003·Granted Mar 13, 2007·0 cites·5 claims
- 1954US2007071734A1ARPE-19 as platform cell line for encapsulated cell-based deliveryTAO WENG·Filed 2006·Application pending·0 cites
- 2051US5700465ABovine serum and bovine IgG as preventives and therapeutives for bovine mastitisAMERICAN CYANAMID CO·Filed 1994·Granted Dec 23, 1997·11 cites·7 claims
- 2146US2010272780A1CELL LINES THAT PRODUCE PROSTAGLANDIN F2 ALPHA (PGF2a) AND USES THEREOFLING VINCENT·Filed 2010·Application pending·0 cites
- 2242US10004804B2Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereofNEUROTECH USA INC·Filed 2015·Granted Jun 26, 2018·0 cites·5 claims
- 2342US2016120695A1Use of pedf in an encapsulated cell-based delivery systemNEUROTECH USA INC·Filed 2015·Application pending·0 cites
- 2442US2015024024A1Cell Lines That Produce Prostaglandin F2 Alpha (PGF2A) And Uses ThereofTAO WENG·Filed 2010·Application pending·0 cites
- 2542US2011111008A1Use of PEDF in an Encapsulated Cell-Based Delivery SystemTAO WENG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Weng Tao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →